Skip to main content
Fig. 5 | BMC Pulmonary Medicine

Fig. 5

From: Prognostic characterization of immune molecular subtypes in non-small cell lung cancer to immunotherapy

Fig. 5

Evaluation of the prognostic model for NSCLC patients. A The forest plot showing the multivariable Cox model results of risk scores and other clinical features. B A combined nomogram for predicting the probability of 1/3/5-year survival for NSCLC patients. C, D The calibration curve of the established nomogram with 3-year and 5-year survival respectively. F DCA curve of the established nomogram showing risk scores could bring more benefit to the prognosis of NSCLC. *p < 0.05; **p < 0.01; ***p < 0.001

Back to article page

BMC Pulmonary Medicine

ISSN: 1471-2466

Contact us